Tandem Diabetes (TNDM) Insider RSU Vesting; Shares Withheld for Taxes
Rhea-AI Filing Summary
Tandem Diabetes Care insider Shannon M. Hansen reported multiple transactions on 08/15/2025 related to restricted stock units (RSUs) and common stock. The filing shows vesting-driven acquisitions: 531, 1,437 and 1,097 RSUs converted into common stock (total underlying 3,065 shares added to direct holdings) and corresponding increases in direct common stock ownership to a reported 7,677 shares of derivative-backed common stock and 19,102 shares of direct common stock at various steps. Several entries show shares withheld to satisfy tax withholding at $10.82 per share; no open-market sales were reported. The securities held indirectly are in the Shannon M. Hansen Trust.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine officer RSU vesting and tax-withholding entries; no open-market sales, limited investor impact.
The Form 4 details customary vesting of RSUs awarded in 2022, 2023 and 2024 and the conversion or settlement mechanics. The transactions include share withholding to satisfy tax obligations at a reported price of $10.82 per share, which reduced the net shares delivered to the reporting person but did not involve market disposals. Reported direct beneficial ownership increases reflect standard compensation vesting rather than purchases or strategic reallocation. Overall, these are compensation-related movements with neutral material impact on capitalization or control.
TL;DR Compensation vesting and trust holdings disclosed correctly; no governance red flags.
The filing identifies Shannon M. Hansen as EVP & Chief Legal Officer and trustee of the Shannon M. Hansen Trust. RSUs awarded under the 2013 and 2023 plans vested according to stated schedules, and the reporting clarifies that some shares were withheld solely for tax withholding rather than sold. The Form 4 properly discloses direct and indirect holdings and the trust relationship. There are no indications of unusual related-party transactions or departures from standard equity compensation practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 531 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 1,437 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 1,097 | $0.00 | -- |
| Exercise | Common Stock | 531 | $0.00 | -- |
| Tax Withholding | Common Stock | 190 | $10.82 | $2K |
| Exercise | Common Stock | 1,437 | $0.00 | -- |
| Tax Withholding | Common Stock | 515 | $10.82 | $6K |
| Exercise | Common Stock | 1,097 | $0.00 | -- |
| Tax Withholding | Common Stock | 393 | $10.82 | $4K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee. Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 23, 2024 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
